Evaluation of the association between ICAM-1 gene polymorphisms and sICAM-1 serum levels in multiple sclerosis (MS) patients in Southeast Iran

International Journal of Genetics and Molecular Biology

Volumn 3, Issue 6, 2011, Pages 81-86

  Sanadgol, Nima ^a   Nikravesh, Abbas ^a   Motalleb, Gholamreza ^a   Roshanzamir, Fariba ^a   Balazade, Toktam ^a   Ramroodi, Nourollah ^b   Khajeh, Hamideh ^a  

^a UNIVERSITY OF ZABOL   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Heterogeneity; Intercellular adhesion molecule 1; Polymorphism; Single nucleotide polymorphisms (SNP)

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; INTERCELLULAR ADHESION MOLECULE 1 GENE; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79961045959     PISSN: None     EISSN: 20069863     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Acar G, Idiman F, Kirkali G, Ozakbas S, Oktay G, Cakmakçi H, Idiman E (2005). Intrathecal sICAM-1 production in multiple sclerosiscorrelation with triple dose Gd-DTPA MRI enhancement and IgG index. J. Neurol., 252: 146-15.
2. Albelda SM, Smith CW, Ward PA (1994). Adhesion molecules and inflammatory injury. FASEB. J., 8: 504-512.
3. Baraczka K, Nékám K, Pozsonyi T, Jakab L, Szongoth M, Seszták M (2001). Concentration of soluble adhesionmolecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation, 9: 49-54.
4. Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak VMA, Haines JL, Hauser SL (2002). Genetic basis for clinical expression in multiple sclerosis. Brain, 125: 150.
5. Braun C, Zahn R, Martin K, Albert E, Folwaczny C (2001). Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease. Clin. Immunol., 101: 357-360.
6. Correale J, Bassani Molinas ML (2003). Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS. J. Neuroimmunol., 140: 198-209.
7. Cournu-Rebeix I, Genin E, Lesca G, Azoulay-Cayla A, Tubridy N, Noe E, Clanet M, Edan G, Clerget-Darpoux F, Semana G, Fontaine B (2003). Intercellular adhesion molecule-1: A protective haplotype against multiple sclerosis. Genes Immun., 4: 518-523.
8. Diamond MS, Staunton DE, Marlin SD, Springer TA (1991). Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulinlike domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell, 65: 961-971.
9. Dorra KH, Saloua JA, Walid Ben A, Imen S, Leila M, Samira M, Tawfik N, Azza F, Yousr G, Taieb Ben A, Khaled A (2009). Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 21(2): 167-175.
10. Gaetani E, Flex A, Pola R, Papaleo P, De Martini D, Pola E, Aloi F, Flore R, Serricchio M, Gasbarrini A, Pola P (2002). The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease, Blood Coagul. Fibrinolysis, 13(6): 483-488.
11. Gearing AJH, Newman W (1993). Circulating adhesion molecules in disease. Immunol. Today, 14: 506-512.
12. Giovannoni G, Lai M, Thorpe J, Kidd D, Chamoun V, Thompson AJ, Miller DH, Feldmann M, Thompson EJ (1997). Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance imaging. Neurology, 48: 1557-1565.
13. Hartung HP, Archelos JJ, Zieslasek J, Gold R, Koltzenburg M, Reiners KH, Toyka KV (1995). Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology, 45(6): S22-S32.
14. Hartung HP, Michels M, Reiners K, Seeldrayers P, Archelos JJ, Toyka KV (1993). Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology, 43: 23-31.
15. Hayflick JS, Kilgannon P, Gallatin WM (1998). The intercellular adhesion molecule (ICAM) family of proteins. Immunol. Res., 17: 313-327.
16. Holder AL, Wolf S, Walshe C, Pandya P, Stanford RE, Smith JD, Rose ML, Lawson C (2008). Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum. Immunol., 69: 71-78.
17. Jander S, Heidenreich F, Stoll G (1993). Serum and CSF levels of soluble ICAM-1 in inflammatory neurologic diseases. Neurology, 43: 1809.
18. Khoury SJ, Orav EJ, Guttmann CR, Kikinis R, Jolesz FA, Weiner HL (1999). Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology, 53: 758-764.
19. Killestein J, Schrijver HM, Crusius JB, Perez C, Uitdehaag BM, Pena AS, Polman CH (2000). Intracellular adhesion molecule-1 polymorphisms and genetic susceptibility to multiple sclerosis: Additional data and meta-analysis. Ann. Neurol., 47: 277.
20. Kronig H, Riedel M, Schwarz MJ, Strassnig M, Moller HJ, Ackenheil M, Muller N (2005). ICAM g241a polymorphism and soluble ICAM-1 serum levels: Evidence for an active immune process in schizophrenia. Neuroimmunomodulation, 12: 54-59.
21. Lee EB, Kim JY, Kim EH, Nam JH, Park KS, Song YW (2004). Intercellular adhesion molecule-1 polymorphisms in Korean patients with rheumatoid arthritis, Tissue Antigens, 64: 473-477.
22. Li YF, Tsao YH, Gauderman WJ, Conti DV, Avol E, Dubeau L, Gilliland FD (2005). Intercellular adhesion molecule-1 and childhood asthma. Hum. Genet., 117: 476-484.
23. Luomala M, Elovaara I, Koivula T, Lehtimaki T (1999). Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis. Ann. Neurol., 45: 546.
24. Marrosu MG, Schirru L, Fadda E, Mancosu C, Lai M, Cocco E, Cucca F (2000). ICAM-1 gene is not associated with multiple sclerosis in Sardinian patients. J. Neurol., 247: 677.
25. McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA (1999). Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. J. Neurol., 246: 87-92.
26. McMurray RW (1996). Adhesion molecules in autoimmune disease. Semin. Arthritis. Rheum., 25: 215.
27. Mycko MP, Kwinkowski M, Tronczynska E, Szymanska B, Selmaj KW (1998). Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann. Neurol., 44: 70-75.
28. Nishimura M, Obayashi H, Maruya E, Ohta M, Tegoshi H, Fukui M, Hasegawa G, Shigeta H, Kitagawa Y, Nakano K, Saji H, Nakamura N (2000). Association between type 1 diabetes age-at-onset and intracellular adhesion molecule 1 (ICAM1) gene polymorphism. Hum. Immunol., 61: 507.
29. Papa A, Danese S, Urgesi R, Grillo A, Guglielmo S, Roberto I, Semeraro S, Scaldaferri F, Pola R, Flex A, Fedeli G, Gasbarrini G, Pola P, Gasbarrini A (2004). Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci., 8: 187.
30. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005). Diagnostic criteria for multiple sclerosis: revisions to the "McDonald criteria." Ann. Neurol., 58: 840-846.
31. Ponthieux A, Lambert D, Herbeth B, Droesch S, Pfister M, Visvikis S (2003). Association between gly241arg icam-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort. Eur. J. Hum. Genet., 11: 679-686.
32. Rieckmann P, Altenhofen B, Riegel A, Kallmann B, Felgenhauer K (1998). Correlation of soluble adhesion molecules in blood and cerebrospinal fluid: with magnetic resonance activity in patients with multiple sclerosis. Mult. Scler., 4: 133-140.
33. Sanadgol N, Mostafaie A, Bahrami G, Mansouri K, Ghanbari F, Bidmeshkipour A (2010). Elaidic acid sustains LPS and TNF-α induced ICAM-1 and VCAM-1 expression on human bone marrow endothelial cells (HBMEC). Clin. Biochem., 43(12): 968-972.
34. Seventer GA, Shimizu Y, Horgan KJ, Shaw S (1990). The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptormediated activation of resting T cells. J. Immunol., 144: 4579.
35. Springer TA (1990). Adhesion receptors of the immune system. Nature, 346: 425.
36. Springer TA (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multiple paradigms. Cell, 76: 301-314.
37. Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Polman CH, Rovira A, de Sa J, Thompson AJ (1999). Primary and transitional progressive MS. Neurology, 52: 839-845.
38. Tsukada N, Matsuda M, Miyagi K, Yanagisawa N (1993). Increased levels of ICAM-1 and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology, 43: 2679.
39. Van der Stolpe A, Van der Saag PT (1996). Intercellular adhesion molecule-1. J. Mol. Med., 74: 13-33.
40. Verity DH, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F, Marr JE, Kanawati CA, Wallace GR, Stanford MR (2000). Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease, Eur. J. Immunogenet., 27: 73-76.
41. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW (1994). Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics, 21: 473.
42. Washington R, Burton J, Todd RF, Newman W, Dragovic L, Dore Duffy P (1994). Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann. Neurol., 35: 89.
43. Wenzel K, Ernst M, Rohde K, Baumann G, Speer A (1996). DNA polymophisms in adhesion molecule genes-A new risk factor for early atherosclerosis. Hum. Genet., 97: 15.
44. Wong D, Prameya R, Dorovini-Zis K (1999). In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: Regulation by ICAM-1, VCAM-1, Eselectin and PECAM-1. J. Neuropathol. Exp. Neurol., 58: 138-152.
45. Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman JW (2000). Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol., 6: S82-S85.
46. Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP (2004). Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. J. Hepatol., 40: 375-379.